This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (13) Citing Articles via Google Scholar Google Scholar Articles by Halpern, S. H. Articles by Walsh, V. Search for Related Content PubMed PubMed Citation Articles by Halpern, S. H. Articles by Walsh, V. Related Collections Economics and Health Care Research Obstetrics Pharmacology

---

OBSTETRIC ANESTHESIA

Epidural Ropivacaine Versus Bupivacaine for Labor: A Meta-Analysis

Department of Anaesthesia, Sunnybrook and Women’s Health Sciences Centre, Women’s College Site and the University of Toronto, Toronto, Ontario, Canada

Address correspondence and reprint requests to Stephen Halpern, MD, MSc, Department of Anesthesia, Sunnybrook and Women’s Health Sciences Centre, Women’s College Campus, 76 Grenville St., Toronto, Ontario, Canada, M5S 1B2. Address e-mail to stephen.halpern{at}swchsc.on.ca

Numerous studies have compared ropivacaine with bupivacaine for labor analgesia. Early studies suggested that obstetrical and some neonatal outcomes were improved when ropivacaine was used. We systematically reviewed and combined the results of the randomized controlled trials that compared ropivacaine with bupivacaine to determine whether or not there was a difference in these outcomes. We searched electronic databases and journals for randomized controlled trials composed of laboring parturients. The primary outcome was the incidence of spontaneous vaginal delivery. We examined other obstetrical, neonatal, and analgesic outcomes. Where possible, these were combined by using metaanalytic techniques and random effects modeling. We found 23 randomized controlled trials composed of 1043 patients receiving ropivacaine and 1031 receiving bupivacaine. There was no significant difference in the incidence of spontaneous vaginal delivery (odds ratio, 1.17; 95% confidence interval, 0.98–1.41; P = 0.12) or any of the other outcomes. Although more studies reported a more frequent incidence of motor block with bupivacaine, the results were heterogeneous and therefore not combined. We conclude that there is no statistically significant difference between the two drugs in the incidence of any obstetrical or neonatal outcome. Further studies using clinically appropriate concentrations of drugs are required to determine whether or not there is a difference in the incidence of motor block.

IMPLICATIONS: This metaanalysis of 23 randomized controlled trials shows that both ropivacaine and bupivacaine provide excellent labor analgesia. There was no significant difference between the two drugs in mode of delivery, maternal satisfaction, or neonatal outcomes. Whether or not there is a difference in motor block at clinically relevant doses is unresolved.

This article has been cited by other articles:

				S. H. Halpern and B. Carvalho Patient-Controlled Epidural Analgesia for Labor Anesth. Analg., March 1, 2009; 108(3): 921 - 928. [Abstract] [Full Text] [PDF]

				Y. Beilin, N. R. Guinn, H. H. Bernstein, J. Zahn, S. Hossain, and C. A. Bodian Local Anesthetics and Mode of Delivery: Bupivacaine Versus Ropivacaine Versus Levobupivacaine Anesth. Analg., September 1, 2007; 105(3): 756 - 763. [Abstract] [Full Text] [PDF]

				L. S. Polley and M. O. Columb Ropivacaine and Bupivacaine: Concentrating on Dosing! Anesth. Analg., May 1, 2003; 96(5): 1251 - 1253. [Full Text] [PDF]